Detection of Carbapenemase and CTX-M Encoding Genes Directly from Bronchoalveolar Lavage Using the CRE and ESBL ELITe MGB Assays: Toward Early and Optimal Antibiotic Therapy Management of Critically Ill Patients with Pneumonia.
Anti-Bacterial Agents
/ pharmacology
Bacterial Proteins
/ genetics
Bronchoalveolar Lavage
/ methods
Carbapenem-Resistant Enterobacteriaceae
/ genetics
Critical Illness
Enterobacteriaceae Infections
/ drug therapy
Genotype
Humans
Microbial Sensitivity Tests
/ methods
Pneumonia
/ drug therapy
Retrospective Studies
beta-Lactamases
/ genetics
ESBL
antimicrobial stewardship
bronchoalveolar lavage fluid
carbapenemase
molecular assay
pneumonia
Journal
Microbial drug resistance (Larchmont, N.Y.)
ISSN: 1931-8448
Titre abrégé: Microb Drug Resist
Pays: United States
ID NLM: 9508567
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
pubmed:
8
7
2020
medline:
8
10
2021
entrez:
8
7
2020
Statut:
ppublish
Résumé
The detection of carbapenemase extended-spectrum β-lactamase (ESBL)-producing
Identifiants
pubmed: 32634044
doi: 10.1089/mdr.2020.0199
doi:
Substances chimiques
Anti-Bacterial Agents
0
Bacterial Proteins
0
beta-Lactamases
EC 3.5.2.6
carbapenemase
EC 3.5.2.6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM